Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.
Accepted 2024-01-18 00:00:00 ET · period of report 2024-01-16 · accession 0001209191-24-001868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-01-18 | 2024-01-16+ | RXRX | Secora Michael | CFO | M - OptEx | $2.22 | +75.0K | 1.01M | +8% | +$166.5K |
| DM | 2024-01-18 | 2024-01-16+ | RXRX | Secora Michael | CFO | S - Sale+OE | $10.35 | -50.0K | 981.0K | -5% | -$517.5K |
| DM | 2024-01-18 | 2024-01-16+ | RXRX | Secora Michael | CFO | M - OptEx | $0.00 | -75.0K | 1.07M | -7% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2024-01-16 | M | A | 37,500 | $2.22 | 993,514 | D | — | — | |
| 2 | Common | Class A Common Stock | 2024-01-16 | S | D | 25,000 | $10.45 | 968,514 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $10.01 to $10.78. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 3 | Common | Class A Common Stock | 2024-01-17 | M | A | 37,500 | $2.22 | 1,006,014 | D | — | — | |
| 4 | Common | Class A Common Stock | 2024-01-17 | S | D | 25,000 | $10.25 | 981,014 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $10.08 to $10.53 The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price. |
| 5 | Derivative | Stock Option (Right to Buy) | 2024-01-17 | M | D | 37,500 | $0.00 | 1,035,135 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F5) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |
| 6 | Derivative | Stock Option (Right to Buy) | 2024-01-16 | M | D | 37,500 | $0.00 | 1,072,635 | D | $2.22 · — to 2030-03-03 | 37,500 Class A Common Stock | (F5) The option, originally for 1,500,000 shares, vests incrementally upon satisfaction of certain liquidity events. |